Literature DB >> 11081207

Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?

R Y Osamura1, S Tahara, K Komatsubara, Y Itoh, H Kajiwara, R Kurotani, N Sanno, A Teramoto.   

Abstract

Pit-1 is a transcription factor which has been reported to regulate differentiation toward GH, PRL and TSH in the anterior pituitary glands. In the human pituitary adenomas, Pit-1 is highly expressed in GH secreting and TSH secreting adenomas as it can well be anticipated. Interestingly, human non-functioning pituitary adenomas also express Pit-1, especially it was expressed in all alpha SU positive nonfunctioning adenomas. The human anterior pituitary cells are special in comparison with rodents in a finding that alpha SU is frequently colocalized with GH. As alpha SU is the first hormone appearing during fetal development in the rodent pituitary glands, it may be postulated that alpha SU Pit-1 positive cells undergo differentiation in the GH cell lineage. From this background, this paper proposes that "alpha SU positive Pit-1 Positive" cells are the ones in the GH cell lineage, more specifically a dedifferentiated cell lineage toward alpha SU/GH/Pit-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081207     DOI: 10.1023/a:1009954409469

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  13 in total

1.  Tissue-specific gene expression in the pituitary: the glycoprotein hormone alpha-subunit gene is regulated by a gonadotrope-specific protein.

Authors:  F Horn; J J Windle; K M Barnhart; P L Mellon
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors.

Authors:  D M Simmons; J W Voss; H A Ingraham; J M Holloway; R S Broide; M G Rosenfeld; L W Swanson
Journal:  Genes Dev       Date:  1990-05       Impact factor: 11.361

3.  In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas.

Authors:  N Sanno; A Teramoto; A Matsuno; J Itoh; S Takekoshi; R Y Osamura
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

4.  Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immunohistochemical analysis.

Authors:  N Sanno; A Teramoto; M Sugiyama; A Matsuno; I Takumi; S Tahara; R Y Osamura
Journal:  Horm Res       Date:  1998

5.  Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.

Authors:  N Sanno; A Sugawara; A Teramoto; Y Abe; P M Yen; W W Chin; R Y Osamura
Journal:  Neuroendocrinology       Date:  1997-04       Impact factor: 4.914

6.  The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3.

Authors:  J J Tremblay; C Lanctôt; J Drouin
Journal:  Mol Endocrinol       Date:  1998-03

7.  Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice.

Authors:  S K Kendall; L C Samuelson; T L Saunders; R I Wood; S A Camper
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

8.  Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.

Authors:  N Sanno; A Teramoto; A Matsuno; R Y Osamura
Journal:  Arch Pathol Lab Med       Date:  1996-01       Impact factor: 5.534

9.  Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining.

Authors:  K Inada; K Oda; H Utsunomiya; J Itoh; R Y Osamura
Journal:  Tokai J Exp Clin Med       Date:  1992-12

10.  Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas.

Authors:  N Sanno; A Teramoto; A Matsuno; S Takekoshi; J Itoh; R Y Osamura
Journal:  Mod Pathol       Date:  1996-05       Impact factor: 7.842

View more
  4 in total

1.  Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Authors:  Yudo Ishii; Masanori Suzuki; Susumu Takekoshi; Noboru Egashira; Michio Yamazaki; Shunsuke Miyai; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

2.  Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution.

Authors:  Robert Y Osamura; Noboru Egashira; Hanako Kajiya; Mao Takei; Maya Tobita; Takashi Miyakoshi; Chie Inomoto; Susumu Takekoshi; Akira Teramoto
Journal:  Acta Histochem Cytochem       Date:  2009-08-11       Impact factor: 1.938

3.  ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.

Authors:  Masanori Suzuki; Noboru Egashira; Hanako Kajiya; Takeo Minematsu; Susumu Takekoshi; Shigeyuki Tahara; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 4.  High-risk pituitary adenomas and strategies for predicting response to treatment.

Authors:  George Kontogeorgos; Eleni Thodou; Robert Y Osamura; Ricardo V Lloyd
Journal:  Hormones (Athens)       Date:  2022-01-21       Impact factor: 2.885

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.